arrow
A

Annette Langer-Gould

Southern California Permanente Medical Group
H指数:47
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy

将利妥昔单抗的低剂量减至每隔24个月输注一次,以及对于在治疗第一年病情稳定的复发型多发性硬化患者疾病活动度的风险。

2026-03-190
PRE
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

首次多发性硬化症疾病调节治疗开始后11年内认知处理速度和身体残疾的轨迹

2023-08-093
OAAI